Back to search

Netherlands· NL-4696110a8901

X-Praep, stroop 2 mg/ml

A senna glycosides product containing sennosiden a+b, registered in Netherlands by Viatris Healthcare B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC A06AB06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedX-Praep, stroop 2 mg/mlATCA06AB06REGISTER NO.NL-4696110a8901PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Senna glycosides is registered in 8 of 19 countries.

Countries holding a registration under ATC A06AB06 (senna glycosides), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Senna glycosides · ATC A06AB06

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SENNOSIDEN A+B
Manufacturer
Viatris Healthcare B.V.
Country
Netherlands (NL)
ATC code
A06AB06
ATC class
Senna glycosides
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    07207

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Senna glycosides in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All senna glycosides products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Cyprus · Senna Remedica
  • Finland · Pursennid Ex Lax, Pursennid Ex-Lax
  • France · Pursennide
  • United Kingdom (Northern Ireland) · Sennosides 12 Years Plus Crescent Pharma, Sennosides 12 Years Plus Farmak Pharmaceuticals Uk
  • Ireland · Senokot
  • Italy · Pursennid
  • Malta · Senna
  • Norway · Pursennid
  • Portugal · Pursennide
  • Sweden · Pursennid Ex-Lax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d82ab056-9ac9-4d8b-8378-da70ebd160ca
GET /v1/drugs/d82ab056-9ac9-4d8b-8378-da70ebd160ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stroop",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h07207_smpc.pdf",
  "strength": null,
  "atc_label": "Senna Glycosides",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg07207",
  "excipients": [
    "CACAOSMAAKSTOF",
    "CHOCOLADESMAAKSTOF",
    "ETHANOL 96 %",
    "KALIUMSORBAAT (E 202)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMHYDROXIDE (E 524)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROSE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "SENNOSIDEN A+B"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h07207.pdf",
  "authorised_at": "1976/06/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "07207",
  "additional_monitoring": "N"
}

See everything about senna glycosides.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.